![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 46, 43300-43304, November 16, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
i TO THESE DOMAINS
REQUIRES PALMITOYLTRANSFERASE ACTIVITY*
From the Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri 63110
Received for publication, May 10, 2001, and in revised form, August 20, 2001
| |
ABSTRACT |
|---|
|
|
|---|
Many signaling proteins are targeted to low
density, sphingomyelin- and cholesterol-enriched membranes, also called
lipid rafts. These domains organize receptor-mediated signaling events at the plasma membrane. Fatty acylation is one mechanism for targeting proteins to rafts. It was therefore of interest to determine if protein
palmitoyltransferase activity is also present in these domains. In this
study, protein palmitoyltransferase activity, assayed using G-protein
alpha subunits as a substrate, was found to be highly enriched in low
density membranes derived from cells that express caveolin as well as
those that do not. Depletion of cellular cholesterol with the drug
methyl- Efficient transmission of extracellular signals relies on the
localization of signaling molecules at the plasma membrane
(PM).1 Signal transducers
such as nonreceptor tyrosine kinases (NRTK) and heterotrimeric G
proteins are positioned at the inner leaflet of the PM to
respond to receptor-generated signals and relay them to intracellular
effectors. Increasing evidence indicates that signaling molecules are
clustered in specialized domains of the PM (reviewed in Refs. 1-3).
These domains have been characterized biochemically as regions that are
enriched in cholesterol and glycosphingolipids (4, 5), are insoluble in
Triton X-100, and exhibit unique buoyancy with respect to other
cellular membranes (5-7). Low density membrane domains are likely to
be present in all cell types and have been termed lipid rafts,
detergent-insoluble glycolipid-enriched membranes, and
detergent-resistant membranes. Caveolae, small nonclathrin-coated
membrane invaginations, are likely to represent a specialized lipid
raft with a characteristic protein coat of oligomerized caveolin
(8).
Numerous signaling molecules are enriched in lipid raft preparations.
Characterization of hormone-stimulated adenylyl cyclase in S49 lymphoma
cells demonstrates that all components of the signaling pathway are
enriched in low density PM fragments (9). Morphological evidence is
consistent with G-protein localization in subdomains of the plasma
membrane. G-protein The functional importance of organizing signaling pathways in PM
subdomains has been demonstrated in several systems, most notably in
hematopoietic cells. Transmembrane signaling through the high affinity
IgE receptor Fc The best-characterized signals that target proteins to lipid rafts are
those that involve fatty acylation. These are
glycophosphatidylinositols (16, 17), tandem amide-linked myristate
and thioester-linked palmitate (18, 19), and tandem-linked palmitate
chains (20). Palmitoylation of the cytoplasmic domains of the
transmembrane proteins LAT (21) and influenza hemagglutinin (22) is
also an important determinant of their raft association. Blocking
palmitoylation of NRTKs by mutation (19) or with inhibitors such as
2-bromopalmitate results in the delocalization of NRTKs from lipid
rafts (23).
Proteins are modified with palmitate by membrane-bound
palmitoyltransferases (reviewed in Refs. 11, 24). Using a variety of
proteins as substrates, palmitoyltransferase activities have been
characterized biochemically, but their molecular entities remain
elusive. There is considerable heterogeneity in the protein motifs that
direct palmitoylation. Furthermore, this modification occurs both on
intracellular membranes and at the PM, suggesting that multiple enzymes
are present in cells. We have studied a protein acyltransferase
activity (PAT) using G-protein Materials--
Soluene-350 was obtained from Packard
Instruments. Diethylpyrocarbonate (DEPC) was purchased from Sigma
Chemical Co. as a 6.9 M stock in isopropanol. DEPC was
diluted in assay buffer and used immediately in experiments.
[3H]Palmitoyl-CoA was prepared and purified as described
previously (25, 27). Myristoylated recombinant G-protein Assay for PAT Activity--
A source of PAT (20 µl) was mixed
with 10 µl of G-protein Cell Culture--
KBC cells (KB cells stably expressing
caveolin) were cultured in MEM supplemented with 10% fetal bovine
serum (FBS), 2 mM glutamine, 150 units/ml penicillin, 50 µg/ml streptomycin, and MEM amino acids (Life Technologies, Inc.).
FBS was heat-inactivated at 56 °C for 30 min. KBC cells were the
gift of Dr. Linda Pike (Washington University).
Cyclodextrin Treatment--
Confluent cells in D150 dishes were
rinsed once with serum-free medium (SFM). Cells were then treated with
10 mM methyl- Detergent-free Preparation of Low Density PM Domains--
Low
density plasma membrane domains were prepared as described previously
(7, 13). Cells were seeded in D150 dishes and allowed to grow until
confluent. Following treatment when appropriate, cells were rinsed once
with cold SFM and scraped into 1-ml ice-cold high pH buffer (150 mM Na2CO3, pH 11, 1 mM
EDTA). The cells were subjected to 20 up and down passes in a Dounce
homogenizer, followed by 10 up and down passes through a
23-gauge needle. The lysate (in a 50-ml conical tube) was
subject to 3 × 30 s sonication pulses by a Virsonic
sonicator set at the maximum setting for a microprobe, or by a Branson
sonicator at setting 4. The sample was sonicated while suspended in ice
water, and each pulse was followed by a 1-min rest period, during which
the probe was immersed in ice water. The lysate (1 ml) was diluted with
1 ml of 80% sucrose in MES-buffered saline (MBS, 25 mM
MES, pH 6.5, 150 mM NaCl, 2 mM EDTA) in the
bottom of an SW41 centrifuge tube. This solution was overlaid with 30%
sucrose in MBS (6 ml) followed by 5% sucrose in MBS (4 ml). The
three-step gradient was subject to centrifugation at 175,000 × g for 3 h at 4 °C in an SW41 rotor. Fractions of 1.2 ml were harvested from the top of the gradient. Prior to assaying PAT
activity, the total cell lysate and fractions 9 and 10 were neutralized
with 1 N HCl.
G-protein Reconstitution into Low Density PM Domains--
Cells
were washed and scraped into high pH buffer as described above. The
lysate was subject to Dounce homogenization and shearing followed by
centrifugation for 30 min at 200,000 × g. The membrane
pellet was resuspended in MBSD (MBS + 1 mM DTT) and subjected to homogenization, shearing, and sonication as for the standard preparation of low density membrane domains. Palmitoylation reactions were performed in volumes of 100 µl containing 10-µl membranes, 5 µM [3H]palmitoyl-CoA, and ~8
µg of G-protein heterotrimer. The reaction was allowed to proceed for
15 min at 30 °C, after which it was placed at the bottom of a
thick-walled TWS55 centrifuge tube. The reaction was mixed with 100 µl of 80% sucrose in MBS and then overlaid with 600 µl of 30%
sucrose in MBS and 400 µl of 5% sucrose in MBS. The samples were
subjected to centrifugation at 45,000 rpm in a TWS55 rotor for 3 h. Fractions of 120 µl were collected from the top of the gradient,
and portions were resolved by SDS-polyacrylamide gel electrophoresis.
The G Immunoblots and Miscellaneous Procedures--
Equal volumes of
fractions from the sucrose gradients were transferred to nitrocellulose
and analyzed by immunoblotting. Caveolin-1 antibody was purchased from
Transduction Laboratories and used at a 1:10,000 dilution. Antibody to
the transferrin receptor was purchased from Zymed
Laboratories Inc. Laboratories and used at a 1:1000 dilution.
Immune complexes were detected using goat anti-rabbit or goat
anti-mouse horseradish peroxidase-conjugated secondary antibody
(1:2000) followed by enhanced chemiluminescence. Protein concentrations
were determined by staining with Amido Black (30).
PAT Activity Is Highly Enriched in Low Density Membranes--
To
determine the distribution of PAT activity in membrane fractions, cell
lysates were prepared from KBC cells using a detergent-free method and
separated on a discontinuous sucrose gradient (7, 13). Fractions were
collected from the top of the gradient and analyzed for PAT activity,
total protein, and markers for membrane compartments (Fig.
1). PAT activity was highest at the
interface of 5 and 35% layers (fraction 4). This enrichment of PAT
activity was significant; a 30- to 50-fold increase in PAT-specific
activity was measured when compared with the starting cell lysate.
Fraction 4 represents the accumulation of low density membranes as
indicated by the presence of caveolin (Fig. 1A) and the
absence of the transferrin receptor (Fig. 1B), a marker for
plasma membrane outside lipid rafts (15). Similarly, the ER resident
protein, grp94 (31), as well as the Golgi-localized p58 (32), were
found exclusively in fractions 9 and 10 (not shown). Although both PAT
activity and caveolin always co-enriched in the low density fraction,
there was variability in the amounts of caveolin and PAT activity in fractions 8-10 (compare Figs. 1A and 2A). This
was likely due to experimental variation in the efficiency of isolation
of low density membranes. It is notable that the amounts of caveolin and PAT activity in fractions containing higher density membranes did
not always correlate well (compare Figs. 1A and
2A). This may reflect an overlapping distribution of PAT
activity and caveolin in subdomains of the plasma membrane (see
"Discussion").
The presence of PAT activity in low density membranes was independent
of caveolin-1 expression. KBC is an epithelial cell line that has been
stably transfected with caveolin-1 and exhibits large numbers of
caveolae on the inner surface of the PM. However, PAT was also enriched
in low density domains isolated from cell lines that do not have
morphological caveolae, including the parental KB cell line, and
neuroblastoma cell lines NG108 and N2A (data not shown).
PAT Activity in Low Density Membrane Domains Is Dependent on
Cholesterol--
Having established that PAT was enriched in low
density membranes, we assessed the dependence of this localization on
the presence of cholesterol. Previous work has shown that the removal of cholesterol by the drug methyl- PAT Activity and the Enrichment of G
To establish that the enrichment of palmitoylated
G In this report, we examined the role of PAT in the distribution of
G The temporal relationship between palmitoylation of G-protein PAT may have an overlapping distribution with caveolin in subdomains of
the plasma membrane, similar to that seen for G PAT activity partially redistributes to membranes of higher density
when cholesterol is depleted, suggesting that its enrichment in
rafts is dependent upon cholesterol. This is not surprising, because
cholesterol is required for the integrity of lipid rafts. PAT activity
can only be solubilized from bovine brain in a nonaggregated form with
high concentrations of Triton X-100 (38) or the ZWITTERGENT Z3-12.2 This resistance to
detergent extraction is consistent with its localization in lipid
rafts. PAT activity is stable in a detergent extract, but the
preparation rapidly loses activity when fractionated through several
chromatographic steps. The observation that PAT is inhibited when
cholesterol is depleted suggests that cholesterol may be an important
stabilizing factor for PAT. Chromatographic separation may remove
lipids required for PAT activity. We have attempted to stabilize
partially purified PAT with exogenously added cholesterol but have not
been successful.2 Further investigation of the lipid
requirements for PAT activity is warranted as specific lipids may be
required to purify this elusive enzyme.
The lipid environment of rafts may impact the lipid substrate
availability for PAT. Raft membrane lipids are believed to exist in a
state similar to the liquid-ordered phase described in model membranes
(39, 40). In this state, lipid acyl chains are tightly packed, highly
ordered, and extended, an environment that favors saturated acyl
chains. Proteins modified with saturated acyl chains would be expected
to partition favorably into liquid-ordered phase domains. In support of
this model, proteins modified with saturated but not unsaturated fatty
acids associate with detergent-resistant membranes in cells (23) and in
model membranes (41). In vitro, PAT uses acyl-CoAs with
saturated or unsaturated acyl chains as substrates (25, 42). However,
the finding that raft proteins are modified with saturated fatty acids
suggests that the pool of acyl-CoAs available to PAT may be enriched in
species with saturated acyl chains.
In addition to its ability to recruit G In summary, we have demonstrated that PAT activity for G-protein
-cyclodextrin resulted in inhibition of palmitoyltransferase
activity and a redistribution of the remaining activity to membranes of
higher density. This effect was reversed by adding cholesterol to
cyclodextrin-treated cells. When reconstituted into cell membranes, the
population of purified recombinant G
i that was
palmitoylated was highly enriched in the low density membrane
fractions, whereas the bulk unmodified G
i-protein was
largely excluded. This effect required palmitoyltransferase activity
and was abolished if the palmitoylated cysteine was mutated. Thus,
palmitoyltransferase facilitates the enrichment of fatty acylated
signaling molecules in plasma membrane subdomains.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
i and
subunits exhibit a punctate
distribution on the PM when visualized by immunofluorescence (9). This
nonuniform distribution of G
in the PM is corroborated by its clustered appearance when detected by immunogold in electron micrographs (10). In T cells, the nonreceptor tyrosine kinases Fyn and
Lck and the palmitoylated, transmembrane protein LAT are localized in
lipid rafts. Activation of the T-cell receptor results in the
recruitment of other components of this signaling pathway into rafts,
including the zeta chain of the T-cell receptor, the tyrosine kinase
ZAP-70, Vav, and phospholipase C
1 (reviewed in Ref. 11).
RI in mast cells requires a cholesterol-dependent association of the receptor with
lipid rafts where the receptor is tyrosine-phosphorylated by the NRTK
lyn (12). In T cells, perturbation of lipid rafts disrupts early steps
in T cell activation (11). Examples can be found in other cell types as
well (13-15), suggesting that concentration of proteins in
cholesterol-rich domains may be a common feature required for the
function of many signaling pathways.
subunits as a substrate (25, 38). We
have previously shown that PAT activity for myristoylated
G
subunits is highly enriched in the PM (25) where it
facilitates the stable association of G
with the PM
(26). In this study, we sought to determine how PAT is distributed in
the PM to address whether it has a role in the localization of fatty
acylated proteins in lipid rafts. We found that PAT is enriched in
lipid raft preparations. Furthermore, we have reconstituted recruitment
of G
to these domains through a mechanism that requires
PAT activity.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
subunits
were purified after co-expression in Escherichia coli with
Saccharomyces cerevisiae N-myristoyl transferase
(28). Recombinant 
C68S was purified from insect cells infected
with recombinant
1 and
2C68S viruses (29).
(2 µg) and 
C68S (2 µg) subunits
that had been diluted in 50 mM sodium Hepes (pH 8.0), 1 mM EDTA, and 1 mM DTT before addition. The
reaction was started by the addition of 20 µl of a mixture containing
[3H]palmitoyl-CoA, MES (pH 6.4), Triton X-100, and DTT
such that the final concentrations in the assay were 0.4-1.0
µM, 100 mM, 0.04%, and 1 mM,
respectively. Assays were incubated for 10 min at 30 °C, terminated
by the addition of 1 ml of 15% trichloroacetic acid and 2% SDS,
incubated at room temperature for at least 15 min, and collected on
glass fiber filters. The filters were washed twice with 2-ml aliquots
of 6% trichloroacetic acid containing 2% SDS, followed by four washes
of 1.5 ml 6% trichloroacetic acid. The filters were dried, and bound
radioactivity was quantitated using liquid scintillation counting.
-cyclodextrin (CD) (Aldrich) made fresh in
SFM for 30 min at 37 °C. The cells were then rinsed once with cold
SFM and harvested. Cholesterol reconstitution was carried out by
incubating cells in CD-cholesterol complexes (0.2 mM
cholesterol) in SFM for 30 min at 37 °C. Complexes were prepared by
dissolving 200 mg of CD in 2.2 ml of water, heating to 80 °C, and
slowly adding 6 mg of cholesterol dissolved in 2:1 isopropanol:CHCl3. This yielded a solution of 6.8 mM cholesterol.
band identified by Coomassie Blue staining was cut
out of the gel and solubilized with Soluene-350 for 3 h at
50 °C, followed by liquid scintillation counting. For DEPC
treatment, 10 µl of membranes was mixed with 2 µl of DEPC diluted
fresh in MBSD (final 5 mM in 12 µl) and incubated at
30 °C for 10 min. The sample was then diluted with MBSD prior to addition of PAT substrates.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (22K):
[in a new window]
Fig. 1.
PAT activity is enriched in low density
membranes. KBC cells were fractionated on sucrose density
gradients as described under "Experimental Procedures." Fractions
were collected from the top of the gradient. PAT activity
(closed circles) was assayed with equal volumes from each
fraction. Note that most of the total protein (open circles)
is present at the bottom of the gradient. A,
PAT-specific activities in this experiment were: total cell lysate, 2.3 pmol/min/mg; fraction 4, 77 pmol/min/mg; fraction 9, 0.64 pmol/min/mg;
fraction 10, 0.57 pmol/min/mg. Caveolin content was assessed by Western
blot analysis of equal portions of fractions 3-10. This experiment is
representative of five experiments with similar results. B,
in a separate experiment, the distribution of PAT activity was compared
with that of the transferrin receptor. This experiment is
representative of two experiments with similar results.
-cyclodextrin (CD) results in
disruption of the integrity of these domains and the delocalization of
raft proteins and lipids (13). Depletion of cholesterol by CD
significantly reduced PAT activity present in fraction 4 (Fig. 2A). The distribution of
caveolin-1 was similarly affected. Compared with the control, more PAT
activity was consistently found in the bottom of the gradient after
cyclodextrin treatment, suggesting at least a partial redistribution of
enzyme activity to membranes of higher density. However, we also
consistently observed inhibition of PAT activity by CD treatment. These
effects were reversed by reconstituting the cells with exogenously
added cholesterol following CD treatment (Fig. 2B and data
not shown). These data demonstrate that cholesterol is an important
determinant of PAT activity and are consistent with the distribution of
the enzyme in cholesterol-enriched subdomains of the PM.

View larger version (21K):
[in a new window]
Fig. 2.
Cyclodextrin inhibits and partially
delocalizes PAT from low density membranes. A, KBC
cells were treated with (closed circles) or without
(open circles) 10 mM CD and harvested using the
standard protocol. Fractions were assayed for PAT activity
(top) or for the presence of caveolin by Western blot
analysis (bottom). This experiment is representative of six
experiments with similar results. B, KBC cells were treated
with or without CD, followed by treatment with or without
CD-cholesterol complexes and fractionated using the standard protocol.
Fractions were then assayed for PAT activity. This experiment is
representative of two experiments with similar results.
i in Low Density
Membranes--
Palmitoylation of newly synthesized G
is
coincident with arrival at the PM (33). The enrichment of PAT in low
density membranes suggested that the enzyme might directly recruit its substrates into rafts through the attachment of palmitate. Therefore, we tested whether exogenously added myristoylated G
could be stably reconstituted into lipid rafts through the action of PAT. A sonicated preparation of total cell membranes was incubated with
purified G-protein heterotrimer and [3H]palmitoyl-CoA to
allow palmitoylation to occur. Following the reaction, low density
membranes were isolated on a sucrose gradient, and the G protein
present in each fraction was analyzed for abundance and
[3H]palmitate incorporation. As shown in Fig.
3A, a significant portion
(typically 30-50%) of palmitoylated G
was present in
the low density fractions. However, nearly all of the G-protein mass
remained at the bottom of the gradient. Thus, palmitoylated G protein
was significantly enriched in the low density membranes. To establish
that this enrichment was dependent on the palmitoylation site,
Cys-3, the same experiment was performed using recombinant G
iC3A. Little [3H]palmitate was
incorporated, and no protein was detected in the low density membrane
fractions (Fig. 3B). The small amount of radiolabeled
protein detected is most likely due to spurious palmitate incorporation
into one or more other cysteine residues. These data clearly
demonstrate that palmitoylated G
i is preferentially and
selectively recruited to low density membranes when compared with
protein that is not palmitoylated.

View larger version (24K):
[in a new window]
Fig. 3.
Palmitoylated
G
is selectively enriched in low
density membranes in vitro. Recombinant
G
i (A) or G
iC3A (B)
plus 
C68S were reconstituted into KBC cell membranes as described
under "Experimental Procedures." Palmitate incorporation was
determined by gel solubilization of the G
i band,
followed by liquid scintillation spectroscopy (graphical
data) and by gel fluorography. Total G
i
distribution was determined by Western blot analysis. This experiment
is representative of four experiments with similar results.
i required PAT activity, it was necessary to
demonstrate that the [3H]palmitate incorporation was due
to an enzymatic process. Prior to the palmitoylation reaction, PAT
activity was inactivated with diethylpyrocarbonate (DEPC).
[3H]Palmitate incorporation was almost entirely abolished
(Fig. 4), indicating that the
incorporation observed in the absence of DEPC was due to active PAT.
Furthermore, the protein that did incorporate
[3H]palmitate was almost entirely confined to fractions 9 and 10, which contained the nonraft membranes. Thus, nonenzymatic
acylation of G
(34) results in association with bulk
membranes, whereas enzymatic acylation appears to be responsible for
the enrichment of palmitoylated proteins in the low density domains.
The selective recruitment of palmitoylated G
i to rafts
in vitro suggests that PAT activity is a critical part of
the mechanism by which its substrates are targeted to lipid rafts.

View larger version (22K):
[in a new window]
Fig. 4.
PAT activity accounts for palmitate
incorporation and enrichment of G
in low density membranes in vitro. G-protein
reconstitution with cell membranes was carried out as described under
"Experimental Procedures," except that an aliquot of membranes was
treated with water (closed circles) or 5 mM DEPC
(open circles) prior to the palmitoylation reaction. This
experiment is representative of three experiments with similar
results.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
i in lipid rafts in the PM. We found that PAT activity for G
is highly enriched in low density membranes,
suggesting that it has an important functional role in targeting
proteins to these domains. Indeed, we were able to selectively recruit palmitoylated G
i to rafts in vitro,
suggesting that PAT activity is a critical part of the mechanism by
which its substrates are enriched in lipid rafts. We have proposed
previously that palmitoylation serves as a targeting signal for PM
localization of G
subunits that are myristoylated and
palmitoylated (24). This hypothesis is based on the kinetic
membrane-trapping model of Silvius and co-workers (35). In this model,
a protein modified with a myristoyl group will cycle on and off
membranes until it encounters a membrane where the protein is
palmitoylated. Although a myristoyl group does not provide sufficient
hydrophobicity for stable membrane association, two lipid modifications
yield a protein that is "trapped" at the membrane. The model has
been extended and refined by studies of the targeting of
G
z, a myristoylated, palmitoylated G
subunit. In this "dock and lock" modification, binding to
G
subunits targets G
to the PM where
palmitoylation then stabilizes G
association with the PM
(26). Our current study extends this model further, suggesting that
palmitoylation occurs in lipid rafts, trapping G
in
these subdomains.
subunits and their localization in lipid rafts has not been studied in
cells, but our data suggest that they would coincide. Interestingly,
the NRTK Fyn is palmitoylated at the PM but does not acquire detergent
resistance, a hallmark of raft localization, until 10-20 min later
(36). Resolution of this apparent discrepancy will require kinetic
analysis of G-protein entry into detergent-resistant membranes and a
better understanding of the substrate range of the PAT activity we have characterized.
. Caveolin and G
biochemically co-fractionate in low
density membranes derived from a variety of cell types and tissues (2). Immunogold electron microscopy reveals that some G
is
associated with caveolae. However, most are clustered in irregular
structures of the plasma membrane that have not been identified
morphologically (9). Recently Oh and Schnitzer (37) reported that, in
lung tissue and in endothelial and epithelial cultured cell lines, the
heterotrimeric G-proteins Gi and Gs appear to
be associated primarily with a lipid raft fraction distinct from
caveolae, whereas Gq
is concentrated in caveolae (37).
Future studies will be necessary to address whether PAT activity is
associated with one or both types of plasma membrane subdomains.
directly into
rafts, the localization of PAT in these domains may have implications for regulation of G
by palmitoylation. Palmitoylation is dynamic, thus PAT must be available for regeneration of palmitoylated G
after palmitate turnover. The co-distribution of PAT
and its substrates in lipid rafts would facilitate repalmitoylation. Agonists stimulate palmitate turnover on G
s and
G
i, and this may have a regulatory role in
desensitization of G-protein responses (43-46). In vitro,
palmitoylated G
i is resistant to deactivation by
RGS proteins (47). Thus, agonist-stimulated depalmitoylation may
permit RGS proteins to stimulate GTPase activity of G
,
thereby accelerating deactivation of the pathway. Repalmitoylation by
PAT would return G
to the RGS-resistant state.
Interestingly, analysis of agonist-stimulated palmitate turnover on
G
s has revealed that there is no net change in the
stoichiometry of palmitoylation. These results suggest that
G
s is rapidly repalmitoylated (48), consistent with the
close proximity of PAT with its substrates in lipid rafts.
subunits is enriched in low density membrane domains of the plasma
membrane. Similar to other raft proteins, PAT's activity in low
density membranes is dependent upon cholesterol. In a cell-free system,
PAT can recruit exogenously added G-protein to these domains, suggesting that PAT is responsible at least in part for the
localization of G-proteins in lipid rafts.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Drs. Linda Pike and Malu Tansey for providing reagents and advice and Dr. Leah Bernstein and members of the laboratory for comments on the manuscript.
| |
FOOTNOTES |
|---|
* This work was supported in part by United States Public Health Service Grant GM51466 (to M. E. L.) and a Mr. and Mrs. Spencer T. Olin predoctoral fellowship (to J. T. D).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
An Established Investigator of the American Heart
Association. To whom correspondence should be addressed: Dept. of Cell
Biology and Physiology, Campus Box 8228, 660 So. Euclid Ave., St.
Louis, MO 63110. Tel.: 314-362-6040; Fax: 314-362-7463; E-mail:
mlinder@cellbio.wustl.edu.
Published, JBC Papers in Press, September 13, 2001, DOI 10.1074/jbc.M104275200
2 J. T. Dunphy, W. K. Greentree, and M. E. Linder, unpublished results.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
PM, plasma membrane;
NRTK, nonreceptor tyrosine kinase;
PAT, protein acyltransferase;
DTT, dithiothreitol;
FBS, fetal bovine serum;
SFM, serum-free medium;
MES, 4-morpholineethanesulfonic acid;
MBS, MES-buffered saline;
DEPC, diethylpyrocarbonate;
CD, methyl-
-cyclodextrin;
MEM, minimal
essential medium;
KBC cells, KB cells stably expressing caveolin;
RGS, regulator of G-protein signaling.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Lisanti, M., Scherer, P., Tang, Z., and Sargiacomo, M. (1994) Trends Cell Biol. 4, 231-235[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Anderson, R. G. W. (1998) Ann. Rev. Biochem. 67, 199-226[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Simons, K., and Ikonen, E. (1997) Nature 387, 569-572[CrossRef][Medline] [Order article via Infotrieve] |
| 4. | Fiedler, K., Kobayashi, T., Kurzchalia, T. V., and Simons, K. (1993) Biochemistry 32, 6365-6373[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Brown, D. A., and Rose, J. K. (1992) Cell 68, 533-544[CrossRef][Medline] [Order article via Infotrieve] |
| 6. |
Smart, E. J.,
Ying, Y.-S.,
Mineo, C.,
and Anderson, R. G. W.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
10104-10108 |
| 7. |
Song, K. S.,
Li, S.,
Okamoto, T.,
Quilliam, L. A.,
Sargiacomo, M.,
and Lisanti, M. P.
(1996)
J. Biol. Chem.
271,
9690-9697 |
| 8. | Rothberg, K. G., Heuser, J. E., Donzell, W. C., Ying, Y.-S., Glenney, J. R., and Anderson, R. G. W. (1992) Cell 68, 673-682[CrossRef][Medline] [Order article via Infotrieve] |
| 9. |
Huang, C.,
Hepler, J. R.,
Chen, L. T.,
Gilman, A. G.,
Anderson, R. G. W.,
and Mumby, S. M.
(1997)
Mol. Biol. Cell
8,
2365-2378 |
| 10. |
Huang, C.,
Duncan, J. A.,
Gilman, A. G.,
and Mumby, S. M.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
412-417 |
| 11. | Resh, M. (1999) Biochim. Biophys. Acta 1451, 1-16[Medline] [Order article via Infotrieve] |
| 12. | Holowka, D., and Baird, B. (2001) Semin. Immunol. 13, 99-105[CrossRef][Medline] [Order article via Infotrieve] |
| 13. |
Pike, L. J.,
and Miller, J. M.
(1998)
J. Biol. Chem.
273,
22298-22304 |
| 14. |
Green, J.,
Zhelesnyak, A.,
Chung, J.,
Lindberg, F.,
Sarfatei, M.,
Frazier, W.,
and Brown, E.
(1999)
J. Cell Biol.
146,
673-682 |
| 15. | Tansey, M., Baloh, R., Milbrandt, J., and Johnson, E. (2000) Neuron 25, 611-623[CrossRef][Medline] [Order article via Infotrieve] |
| 16. |
Arreaza, G.,
and Brown, D.
(1995)
J. Biol. Chem.
270,
23641-23647 |
| 17. |
Rodgers, W.,
Crise, B.,
and Rose, J. K.
(1994)
Mol. Cell. Biol.
14,
5384-5391 |
| 18. |
Galbiati, F.,
Volonte, D.,
Meani, D.,
Milligan, G.,
Lublin, D. M.,
Lisanti, M. P.,
and Parenti, M.
(1999)
J. Biol. Chem.
274,
5843-5850 |
| 19. |
Shenoy-Scaria, A. M.,
Dietzen, D. J.,
Kwong, J.,
Link, D. C.,
and Lublin, D. M.
(1994)
J. Cell Biol.
126,
353-363 |
| 20. |
Arni, S.,
Keilbaugh, S. A.,
Ostermeyer, A. G.,
and Brown, D. A.
(1998)
J. Biol. Chem.
273,
28478-28485 |
| 21. | Zhang, W., Trible, R., and Samelson, L. (1998) Immunity 9, 239-246[CrossRef][Medline] [Order article via Infotrieve] |
| 22. |
Melkonian, K. A.,
and Brown, D. A.
(1999)
J. Biol. Chem.
274,
3910-3917 |
| 23. |
Webb, Y.,
Hermida-Matsumoto, L.,
and Resh, M.
(2000)
J. Biol. Chem.
275,
261-270 |
| 24. | Dunphy, J. T., and Linder, M. E. (1998) Biochim. Biophys. Acta 1436, 245-261[Medline] [Order article via Infotrieve] |
| 25. |
Dunphy, J. T.,
Greentree, W. K.,
Manahan, C. L.,
and Linder, M. E.
(1996)
J. Biol. Chem.
271,
7154-7159 |
| 26. |
Fishburn, C.,
Pollitt, S.,
and Bourne, H.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
1085-1090 |
| 27. | Taylor, D., Weber, N., Hogge, L., and Underhill, E. (1990) Anal. Biochem. 184, 311-316[CrossRef][Medline] [Order article via Infotrieve] |
| 28. | Mumby, S. M., and Linder, M. E. (1993) Methods Enzymol. 237, 254-268 |
| 29. |
Iniguez-Lluhi, J.,
Simon, M. I.,
Robishaw, J. D.,
and Gilman, A. G.
(1992)
J. Biol. Chem.
267,
23409-23417 |
| 30. | Schaffner, W., and Weissman, C. (1973) Anal. Biochem. 56, 502-514[CrossRef][Medline] [Order article via Infotrieve] |
| 31. |
Maki, R. G.,
Old, L. J.,
and Srivastava, P. K.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
5658-5662 |
| 32. |
Saraste, J.,
Palade, G. E.,
and Farquhar, M. G.
(1987)
J. Cell Biol.
105,
2021-2029 |
| 33. |
Fishburn, C. S.,
Herzmark, P.,
Morales, J.,
and Bourne, H. R.
(1999)
J. Biol. Chem.
274,
18793-18800 |
| 34. |
Duncan, J. A.,
and Gilman, A. G.
(1996)
J. Biol. Chem.
271,
23594-23600 |
| 35. | Shahinian, S., and Silvius, J. R. (1995) Biochemistry 34, 3813-3822[CrossRef][Medline] [Order article via Infotrieve] |
| 36. |
van't Hof, W.,
and Resh, M. D.
(1997)
J. Cell Biol.
136,
1023-1035 |
| 37. |
Oh, P.,
and Schnitzer, J.
(2001)
Mol. Biol. Cell
12,
685-698 |
| 38. | Dunphy, J. T., Schroeder, H., Leventis, R., Greentree, W. K., Knudsen, J. K., Silvius, J. R., and Linder, M. E. (2000) Biochim. Biophys. Acta 1485, 185-198[Medline] [Order article via Infotrieve] |
| 39. | Brown, D. A., and London, E. (1998) Annu. Rev. Cell Dev. Biol. 14, 111-136[CrossRef][Medline] [Order article via Infotrieve] |
| 40. |
Schroeder, R.,
London, E.,
and Brown, D.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
12130-12134 |
| 41. |
Moffett, S.,
Brown, D. A.,
and Linder, M. E.
(2000)
J. Biol. Chem.
275,
2191-2198 |
| 42. |
Berthiaume, L.,
and Resh, M.
(1995)
J. Biol. Chem.
270,
22399-22405 |
| 43. |
Degtyarev, M. Y.,
Spiegel, A. M.,
and Jones, T. L. Z.
(1993)
J. Biol. Chem.
268,
23769-23772 |
| 44. |
Mumby, S. M.,
Kleuss, C.,
and Gilman, A. G.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
2800-2804 |
| 45. | Wedegaertner, P. B., and Bourne, H. R. (1994) Cell 77, 1063-1070[CrossRef][Medline] [Order article via Infotrieve] |
| 46. |
Chen, C.,
and Manning, D.
(2000)
J. Biol. Chem.
275,
23516-23522 |
| 47. |
Tu, Y.,
Wang, J.,
and Ross, E. M.
(1997)
Science
278,
1132-1135 |
| 48. | Jones, T. L., Degtyarev, M. Y., and Backlund, P. S., Jr. (1997) Biochemistry 36, 7185-7191[CrossRef][Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
Q. Zeng, X. Wang, and M. P. Running Dual Lipid Modification of Arabidopsis G{gamma}-Subunits Is Required for Efficient Plasma Membrane Targeting Plant Physiology, March 1, 2007; 143(3): 1119 - 1131. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-Y. Yu, K.-J. Lee, L. Gao, and M. M. C. Lai Palmitoylation and Polymerization of Hepatitis C Virus NS4B Protein. J. Virol., June 1, 2006; 80(12): 6013 - 6023. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Swarthout, S. Lobo, L. Farh, M. R. Croke, W. K. Greentree, R. J. Deschenes, and M. E. Linder DHHC9 and GCP16 Constitute a Human Protein Fatty Acyltransferase with Specificity for H- and N-Ras J. Biol. Chem., September 2, 2005; 280(35): 31141 - 31148. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Roy, S. Plowman, B. Rotblat, I. A. Prior, C. Muncke, S. Grainger, R. G. Parton, Y. I. Henis, Y. Kloog, and J. F. Hancock Individual Palmitoyl Residues Serve Distinct Roles in H-Ras Trafficking, Microlocalization, and Signaling Mol. Cell. Biol., August 1, 2005; 25(15): 6722 - 6733. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cherukuri, R. H. Carter, S. Brooks, W. Bornmann, R. Finn, C. S. Dowd, and S. K. Pierce B Cell Signaling Is Regulated by Induced Palmitoylation of CD81 J. Biol. Chem., July 23, 2004; 279(30): 31973 - 31982. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bunemann, M. Frank, and M. J. Lohse From The Cover: Gi protein activation in intact cells involves subunit rearrangement rather than dissociation PNAS, December 23, 2003; 100(26): 16077 - 16082. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Rubin and F. Ismail-Beigi Distribution of Glut1 in detergent-resistant membranes (DRMs) and non-DRM domains: effect of treatment with azide Am J Physiol Cell Physiol, August 1, 2003; 285(2): C377 - C383. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Baker, H. Zheng, J. Walker, J. L. Coloff, and J. E. Buss Distinct Rates of Palmitate Turnover on Membrane-bound Cellular and Oncogenic H-Ras J. Biol. Chem., May 23, 2003; 278(21): 19292 - 19300. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hiol, P. C. Davey, J. L. Osterhout, A. A. Waheed, E. R. Fischer, C.-K. Chen, G. Milligan, K. M. Druey, and T. L. Z. Jones Palmitoylation Regulates Regulators of G-protein Signaling (RGS) 16 Function: I. MUTATION OF AMINO-TERMINAL CYSTEINE RESIDUES ON RGS16 PREVENTS ITS TARGETING TO LIPID RAFTS AND PALMITOYLATION OF AN INTERNAL CYSTEINE RESIDUE J. Biol. Chem., May 23, 2003; 278(21): 19301 - 19308. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Percherancier, B. Lagane, T. Planchenault, I. Staropoli, R. Altmeyer, J.-L. Virelizier, F. Arenzana-Seisdedos, D. C. Hoessli, and F. Bachelerie HIV-1 Entry into T-cells Is Not Dependent on CD4 and CCR5 Localization to Sphingolipid-enriched, Detergent-resistant, Raft Membrane Domains J. Biol. Chem., January 24, 2003; 278(5): 3153 - 3161. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lobo, W. K. Greentree, M. E. Linder, and R. J. Deschenes Identification of a Ras Palmitoyltransferase in Saccharomyces cerevisiae J. Biol. Chem., October 18, 2002; 277(43): 41268 - 41273. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Berditchevski, E. Odintsova, S. Sawada, and E. Gilbert Expression of the Palmitoylation-deficient CD151 Weakens the Association of alpha 3beta 1 Integrin with the Tetraspanin-enriched Microdomains and Affects Integrin-dependent Signaling J. Biol. Chem., September 27, 2002; 277(40): 36991 - 37000. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Goligorsky, H. Li, S. Brodsky, and J. Chen Relationships between caveolae and eNOS: everything in proximity and the proximity of everything Am J Physiol Renal Physiol, July 1, 2002; 283(1): F1 - F10. [Abstract] [Full Text] [PDF] |
||||
![]() |